DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

2.07 0.03 (1.47%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RIGL $2.07 1.47%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.08
Previous Close $2.04
Daily Range $1.98 - $2.10
52-Week Range $1.56 - $5.00
Market Cap $181.7M
P/E Ratio -2.10
Dividend (Yield) $0.00 (0.0%)
Volume 353,266
Average Daily Volume 495,029
Current FY EPS -$1.12

Sector

Healthcare

Industry

Drugs

Rigel Pharmaceuticals, Inc. (RIGL) Description

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Website: http://www.rigel.com/

News & Commentary Rss Feed

Why VAALCO Energy, Rigel Pharmaceuticals, and Companhia Siderurgica Nacional Are Today's 3 Best Stoc

The S&P 500 dips for a second-straight day following weak economic data while VAALCO Energy, Rigel, and Companhia Siderurgica Nacional shares surge by double-digits.

What You Need to Know About the Roche-InterMune Deal

InterMune's Roche Deal Sends Peer Group Up

Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog

Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today

Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug

Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug Trial

Sector Update: Health Care

Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog

Rigel Initiates Phase 3 Studies Of Fostamatinib In ITP

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

See More RIGL News...

RIGL's Top Competitors

RIGL $2.07 (1.47%)
Current stock: RIGL
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB